Europe Liver Cirrhosis Market and Competitive Landscape – 2017

1. Liver Cirrhosis: Disease Overview

1.1. Liver Cirrhosis Symptoms

1.2. Liver Cirrhosis Etiology

1.3. Liver Cirrhosis Diagnosis

1.4. Liver Cirrhosis Treatment Options

2. Liver Cirrhosis Pipeline Insights

2.1. Liver Cirrhosis Phase 3 Clinical Trials

2.2. Liver Cirrhosis Phase 2 Clinical Trials

2.3. Liver Cirrhosis Phase 1 Clinical Trials

3. Liver Cirrhosis Epidemiology Analysis

4. Germany Liver Cirrhosis Market Insights

4.1. Marketed Products for Liver Cirrhosis in Germany

4.2. Germany Liver Cirrhosis Market Size & Forecast

4.3. Germany Liver Cirrhosis Product Sales Forecast

4.4. Germany Liver Cirrhosis Market Share Analysis

5. France Liver Cirrhosis Market Insights

5.1. Marketed Products for Liver Cirrhosis in France

5.2. France Liver Cirrhosis Market Size & Forecast

5.3. France Liver Cirrhosis Product Sales Forecast

5.4. France Liver Cirrhosis Market Share Analysis

6. Italy Liver Cirrhosis Market Insights

6.1. Marketed Products for Liver Cirrhosis in Italy

6.2. Italy Liver Cirrhosis Market Size & Forecast

6.3. Italy Liver Cirrhosis Product Sales Forecast

6.4. Italy Liver Cirrhosis Market Share Analysis

7. Spain Liver Cirrhosis Market Insights

7.1. Marketed Products for Liver Cirrhosis in Spain

7.2. Spain Liver Cirrhosis Market Size & Forecast

7.3. Spain Liver Cirrhosis Product Sales Forecast

7.4. Spain Liver Cirrhosis Market Share Analysis

8. UK Liver Cirrhosis Market Insights

8.1. Marketed Products for Liver Cirrhosis in UK

8.2. UK Liver Cirrhosis Market Size & Forecast

8.3. UK Liver Cirrhosis Product Sales Forecast

8.4. UK Liver Cirrhosis Market Share Analysis

9. Europe Liver Cirrhosis Market Insights

9.1. Europe Liver Cirrhosis Market Size & Forecast

9.2. Europe Liver Cirrhosis Product Sales Forecast

9.3. Europe Liver Cirrhosis Market Share Analysis

10. Research Methodology

LIST OF TABLES

Table 1: Liver Cirrhosis Phase 3 Clinical Trials, Global, 2017

Table 2: Liver Cirrhosis Phase 2 Clinical Trials, Global, 2017

Table 3: Liver Cirrhosis Phase 1 Clinical Trials, Global, 2017

Table 4: Liver Cirrhosis Prevalence by EU5 Countries, 2012 - 2021

Table 5: Marketed Products for Liver Cirrhosis in Germany, 2017

Table 6: Germany Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 7: Germany Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Table 8: Germany Liver Cirrhosis Market Trends, 2012 - 2021

Table 9: Marketed Products for Liver Cirrhosis in France, 2017

Table 10: France Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 11: France Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Table 12: France Liver Cirrhosis Market Trends, 2012 - 2021

Table 13: Marketed Products for Liver Cirrhosis in Italy, 2017

Table 14: Italy Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 15: Italy Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Table 16: Italy Liver Cirrhosis Market Trends, 2012 - 2021

Table 17: Marketed Products for Liver Cirrhosis in Spain, 2017

Table 18: Spain Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 19: Spain Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Table 20: Spain Liver Cirrhosis Market Trends, 2012 - 2021

Table 21: Marketed Products for Liver Cirrhosis in UK, 2017

Table 22: UK Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 23: UK Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Table 24: UK Liver Cirrhosis Market Trends, 2012 - 2021

Table 25: Europe Liver Cirrhosis Market Size & Forecast ($mn), 2012 - 2021

Table 26: Europe Liver Cirrhosis Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Liver Cirrhosis Pipeline by Phase (%), Global, 2017

Figure 2: Liver Cirrhosis Prevalence by EU5 Countries, 2012 - 2021

Figure 3: Germany Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 4: Germany Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 5: Germany Liver Cirrhosis Market Share by Products (%), 2016

Figure 6: Germany Liver Cirrhosis Market - Future Market Share (%), 2021

Figure 7: France Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 8: France Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 9: France Liver Cirrhosis Market Share by Products (%), 2016

Figure 10: France Liver Cirrhosis Market - Future Market Share (%), 2021

Figure 11: Italy Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 12: Italy Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 13: Italy Liver Cirrhosis Market Share by Products (%), 2016

Figure 14: Italy Liver Cirrhosis Market - Future Market Share (%), 2021

Figure 15: Spain Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 16: Spain Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 17: Spain Liver Cirrhosis Market Share by Products (%), 2016

Figure 18: Spain Liver Cirrhosis Market - Future Market Share (%), 2021

Figure 19: UK Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 20: UK Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 21: UK Liver Cirrhosis Market Share by Products (%), 2016

Figure 22: UK Liver Cirrhosis Market - Future Market Share (%), 2021

Figure 23: Europe Liver Cirrhosis Market Size ($mn), 2012 - 2021

Figure 24: Europe Liver Cirrhosis Product Sales ($mn), 2012 - 2021

Figure 25: Europe Liver Cirrhosis Market Share by Products (%), 2016

Figure 26: Europe Liver Cirrhosis Market - Future Market Share (%), 2021

Europe Liver Cirrhosis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Liver Cirrhosis Market and Competitive Landscape – 2017, provides comprehensive insights into Liver Cirrhosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Liver Cirrhosis market size and drug sales. This research also provides insights into Liver Cirrhosis epidemiology and late stage pipeline.
The report is classified into nine sections – Liver Cirrhosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Liver Cirrhosis pipeline insights covering late stage clinical trials pipeline; Liver Cirrhosis prevalence trends by countries; Liver Cirrhosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

• Liver Cirrhosis pipeline: Find out the drugs in clinical trials for Liver Cirrhosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Liver Cirrhosis epidemiology: Find out the prevalence of Liver Cirrhosis by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Liver Cirrhosis products: Identify key products marketed and prescribed for Liver Cirrhosis by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Liver Cirrhosis market size: Find out the market size for Liver Cirrhosis drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Liver Cirrhosis drug sales: Find out the sales of Liver Cirrhosis drugs by countries – Europe, Germany, France, Italy, Spain, UK
• Liver Cirrhosis drugs sales forecast: Sales forecast for Liver Cirrhosis drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Liver Cirrhosis market share analysis: Find out the market shares of Liver Cirrhosis drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Liver Cirrhosis drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Liver Cirrhosis market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Liver Cirrhosis market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies